Literature DB >> 31102546

Intra-abdominal infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Ghady Haidar1,2, Michael Green3,4.   

Abstract

This new guideline from the AST IDCOP reviews intra-abdominal infections (IAIs), which cause substantial morbidity and mortality among abdominal SOT recipients. Each transplant type carries unique risks for IAI, though peritonitis occurs in all abdominal transplant recipients. Biliary infections, bilomas, and intra-abdominal and intrahepatic abscesses are common after liver transplantation and are associated with the type of biliary anastomosis, the presence of vascular thrombosis or ischemia, and biliary leaks or strictures. IAIs after kidney transplantation include renal and perinephric abscesses and graft-site candidiasis, which is uncommon but may require allograft nephrectomy. Among pancreas transplant recipients, duodenal anastomotic leaks can have catastrophic consequences, and polymicrobial abscesses can lead to graft loss and death. Intestinal transplant recipients are at the highest risk for sepsis, infection due to multidrug-resistant organisms, and death from IAI, as the transplanted intestine is a contaminated, highly immunological, pathogen-rich organ. Source control and antibiotics are the cornerstone of the management of IAIs. Empiric antimicrobial regimens should be tailored to local susceptibility patterns and pathogens with which the patient is known to be colonized, with subsequent optimization once the results of cultures are reported.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  abscess; anastomotic leak; bacteremia; biloma; cholangitis; intestinal transplant; kidney transplant; liver transplant; pancreas transplant; rejection

Year:  2019        PMID: 31102546     DOI: 10.1111/ctr.13595

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  5 in total

1.  Ventriculoperitoneal shunt management in children undergoing liver transplantation.

Authors:  Michael J Cools; Elizabeth Haley Vance; Christopher M Bonfield
Journal:  Childs Nerv Syst       Date:  2021-11-10       Impact factor: 1.532

2.  Therapeutic Drug Monitoring of Amphotericin-B in Plasma and Peritoneal Fluid of Pediatric Patients after Liver Transplantation: A Case Series.

Authors:  Francesca Tortora; Luigi Dei Giudici; Raffaele Simeoli; Fabrizio Chiusolo; Sara Cairoli; Paola Bernaschi; Roberto Bianchi; Sergio Giuseppe Picardo; Carlo Dionisi Vici; Bianca Maria Goffredo
Journal:  Antibiotics (Basel)       Date:  2022-05-11

Review 3.  Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit.

Authors:  Aaron Kaviani; Dilek Ince; David A Axelrod
Journal:  Curr Transplant Rep       Date:  2020-01-24

4.  Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study.

Authors:  S Dubler; M Lenz; S Zimmermann; D C Richter; K H Weiss; A Mehrabi; M Mieth; T Bruckner; M A Weigand; T Brenner; A Heininger
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-31       Impact factor: 4.887

5.  Peritoneal Dialysis After Liver Transplantation: A Systematic Review.

Authors:  Jean Maxime Côté; Isabelle Ethier; Héloïse Cardinal; Marie-Noëlle Pépin
Journal:  Can J Kidney Health Dis       Date:  2021-07-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.